Acinetobacter species meningitis in children: A case series from Karachi, Pakistan

Journal of Infection in Developing Countries

Volumn 5, Issue 11, 2011, Pages 809-814

  Saleem, Ali Faisal ^a   Shah, Muhammad Shafaat ^a   Shaikh, Abdul Sattar ^a   Mir, Fatima ^a   Zaidi, Anita K M ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Children; Mortality; Multidrug resistant acinetobacter meningitis; Neurosurgical procedure

Indexed keywords

AMIKACIN; CEFTRIAXONE; POLYMYXIN;

ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL ARTICLE; HUMAN; INFANT; LENGTH OF STAY; MENINGITIS; NEUROSURGERY; PAKISTAN; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 82055185761     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1697     Document Type: Article

References (30)

1. Saleem AF, Ahmed I, Mir F, Ali SR, Zaidi AK (2009) Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan. J Infect Dev Ctries 4: 30-37.
2. Talbot GH, Bradley J, Edwards JE Jr., Gilbert D, Scheld M, Bartlett JG (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668.
3. Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL (2009) Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 9: 245-255.
4. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
5. Landman D, Georgescu C, Martin DA, Quale J (2008) Polymyxins revisited. Clin Microbiol Rev 21: 449-465.
6. Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME (2008) Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62: 45-55.
7. Ray L, Levasseur K, Nicolau DP, Scheetz MH (2010) Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis. Ann Pharmacother 440: 582-586.
8. Lee SY, Lee JW, Jeong DC, Chung SY, Chung DS, Kang JH (2008) Multidrug-resistant Acinetobacter meningitis in a 3-year-old boy treated with i.v. colistin. Pediatr Int 50: 584-585.
9. Ozaki T, Nishimura N, Arakawa Y, Suzuki M, Narita A, Yamamoto Y, Koyama N, Nakane K, Yasuda N, Funahashi K (2009) Community-acquired Acinetobacter baumannii meningitis in a previously healthy 14-month-old boy. J Infect Chemother 15: 322-324.
10. RP. HTG. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lipponcott Williames and Wilkings. 2004: 1659-1702.
11. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36: 309-332.
12. Irfan S, Zafar A, Guhar D, Ahsan T, Hasan R (2008) Metallo-beta-lactamase-producing clinical isolates of Acinetobacter species and Pseudomonas aeruginosa from intensive care unit patients of a tertiary care hospital. Indian J Med Microbiol 26: 243-245.
13. Clinical and laboratory standard institute (2006) Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. Approved standards M6A-2. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
14. Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39: 183-190.
15. Tan TY and Ng LS (2006) Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemother 58: 864-867.
16. Mirza IA, Hussain A, Abbasi SA, Malik N, Satti L, Farwa U (2011) Ambu Bag as a Source of Acinetobacter baumannii Outbreak in an Intensive Care Unit. J Coll Physicians Surg Pak 21: 176-178.
17. Krol V, Hamid NS, Cunha BA (2009) Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect 71: 176-180.
18. Dalgic N, Ceylan Y, Sancar M, Telhan L, Kafadar I, Cavusoglu H, Ceylan O, Hasim O (2009) Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Ann Trop Paediatr 29: 141-147.
19. Michalopoulos A and Falagas ME (2008) Colistin and polymyxin B in critical care. Crit Care Clin 24: 377-391.
20. Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS (2009) Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity. Diagn Microbiol Infect Dis 65: 431-434.
21. Kuo LC, Teng LJ, Yu CJ, Ho SW, Hsueh PR (2004) Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 42: 1759-1763.
22. Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, Chung DR, Peck KR, Song JH (2007) High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 60: 1163-1167.
23. Reis AO, Luz DA, Tognim MC, Sader HS, Gales AC (2003) Polymyxin-resistant Acinetobacter spp. isolates: what is next? Emerg Infect Dis 9: 1025-1027.
24. Ozdemir H, Tapisiz A, Ciftci E, Ince E, Mokhtari H, Guriz H, Aysev AD, Dogru U (2010) Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis. Infection 38: 241-244.
25. Falagas ME, Bliziotis IA, Tam VH (2007) Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 29: 9-25.
26. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J (2002) Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 21: 212-214.
27. Maragakis LL, Perl TM (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 460: 1254-1263.
28. Rodriguez Guardado ABA, Asensi V, Perez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Carton JA (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61: 908-913.
29. Fulnecky EJ, Wright D, Scheld WM, Kanawati L, Shoham S (2005) Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. J Infect. 51: e249-251.
30. Gilbert VE, Beals JD Jr., Natelson SE, Tyler WA (1986) Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics. Neurosurgery 18: 402-406.